ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Clinical trials for ADVANCED TRIPLE-NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED TRIPLE-NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED TRIPLE-NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug targets Hard-to-Treat breast cancer in Early-Stage trial
Disease control Not yet recruitingThis study tests whether the drug Sacituzumab govitecan can slow down advanced triple-negative breast cancer when used as the first treatment. About 24 adults who have not had prior treatment for advanced disease will receive the drug on days 1 and 8 of each 21-day cycle. Researc…
Matched conditions: ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Nathalie Levasseur • Aim: Disease control
Last updated May 26, 2026 10:39 UTC
-
New pill takes on tough breast cancer in first human trial
Disease control Not yet recruitingThis study tests an experimental oral drug called Zn-Telomir in people with advanced or metastatic triple-negative breast cancer that has worsened after other treatments. The trial has two parts: first, finding a safe dose, then checking if the drug can shrink tumors. About 76 ad…
Matched conditions: ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Telomir Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 10:34 UTC
-
Right care, right time: new model matches palliative support to patient needs
Symptom relief Not yet recruitingThis study tests a flexible palliative care model for 400 people with advanced heart failure or certain cancers. Care teams add more specialists—like social workers or nurses—as symptoms get worse. The goal is to improve quality of life and ensure patients get the right level of …
Matched conditions: ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated May 26, 2026 10:28 UTC
-
New study aims to stop chemo side effect in breast cancer patients
Symptom relief Not yet recruitingThis study tests whether giving atropine before chemotherapy can prevent severe diarrhea in people with advanced breast cancer. About 30 participants will receive atropine alongside the drug sacituzumab govitecan. The goal is to make treatment more tolerable by reducing a common …
Matched conditions: ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: MedSIR • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC